Last reviewed · How we verify

NCT05459363: I-THINC

Neuromuscular Cognitive Training

Completed NA Last updated 4 June 2024
What this trial tests

NA trial testing I-THINC in Injury;Sports in 10 participants. Completed in 15 October 2022.

Timeline
23 August 2022
Primary endpoint
15 October 2022
15 October 2022

Quick facts

Lead sponsorKe'La H Porter
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment10
Start date23 August 2022
Primary completion15 October 2022
Estimated completion15 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ke'La H Porter

Who can join

Adults 18 to 30, any sex, with Injury;Sports. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will utilize a quasi-experimental, multiple baseline pretest-posttest design where participants will complete postural stability assessments, physical performance assessments, and questionnaires to evaluate perceptions toward injury prevention before and after completing a 6-week neuromuscular-cognitive prevention program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Injury;Sports

Currently open trials in the same condition.

Other Ke'La H Porter trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05459363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing